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Not all obese subjects have an adverse metabolic profile predisposing them to 
developing type 2 diabetes or cardiovascular disease. The BioSHaRE-
EU Healthy Obese Project aims to gain insights into the consequences of 
(healthy) obesity using data on risk factors and phenotypes across several large-
scale cohortstudies. Aim of this study was to describe 
the prevalence of obesity, metabolic syndrome (MetS) 
and metabolically healthy obesity (MHO) in ten participating studies. 
METHODS: 
Ten different cohorts in seven countries were combined, using data transformed into 
a harmonized format. All participants were of European origin, with age 18-80 years. 
They had participated in a clinical examination for anthropometric and blood 
pressure measurements. Blood samples had been drawn for analysis of lipids and 
glucose. Presence of MetS was assessed in those with obesity (BMI ≥ 30 kg/m2) 
based on the 2001 NCEP ATP III criteria, as well as an adapted set of less strict 
criteria. MHO was defined as obesity, having none of the MetS components, and no 
previous diagnosis of cardiovascular disease. 
RESULTS: 
Data for 163,517 individuals were available; 17% were obese (11,465 men and 
16,612 women). The prevalence of obesity varied from 11.6% in the Italian 
CHRIS cohort to 26.3% in the German KORA cohort. The age-standardized 
percentage of obese subjects with MetS ranged in women from 24% in CHRIS to 
65% in the Finnish Health2000 cohort, and in men from 43% in CHRIS to 78% in the 
Finnish DILGOM cohort, with elevated blood pressure the most frequently occurring 
factor contributing to the prevalence of the metabolic syndrome. The age-
standardized prevalence of MHO varied in women from 7% in Health2000 to 28% in 
NCDS, and in men from 2% in DILGOM to 19% in CHRIS. MHO was more prevalent 
in women than in men, and decreased with age in both sexes. 
CONCLUSIONS: 
Through a rigorous harmonization process, the BioSHaRE-EU consortium was able 
to compare key characteristics defining the metabolically healthy obese phenotype 
across ten cohort studies. There is considerable variability in 
the prevalence of healthy obesity across the different European populations studied, 
even when unified criteria were used to classify this phenotype 
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